Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01833403 · ClinicalTrials.gov registry record · NA

Metabolomic Analysis of Hepatic Insulin Resistance

A NA study, sponsored by University of Minnesota.

Completed
Registry status
NA
Development phase
4
Enrollment target

NCT01833403: Completed NA study, sponsored by University of Minnesota.

NCT01833403 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01833403, a NA study, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
NA
Development phase
4 participants
Enrollment target

Study Summary

This is a pilot study to show that it is possible to identify the specific types of fats in blood, adipose tissue, and liver tissue. The study doctors hope to use the analysis of these fats to learn more about nonalcoholic fatty liver disease (NFLD). Nonalcoholic fatty liver disease is the accumulation of fat in the liver of people who have minimal alcohol exposure. Nonalcoholic Fatty Liver Disease is associated with obesity and insulin resistance, and predicts development of Type 2 Diabetes. The study doctors are interested in looking at the relationship between liver fat and insulin resistance.

Interventions

  • OTHER Hyperinsulinemic-euglycemic clamp

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2013-04
Est. Completion 2014-03
Phase NA
University of Minnesota

966 total trials

What the finished NCT01833403 record still lists

NCT01833403 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which Hyperinsulinemic-euglycemic clamp is the first listed.

NCT01833403 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01833403 about?

NCT01833403 is a clinical study titled "Metabolomic Analysis of Hepatic Insulin Resistance". This is a pilot study to show that it is possible to identify the specific types of fats in blood, adipose tissue, and liver tissue. The study doctors hope to use the analysis of these fats to learn more about nonalcoholic fatty liver disease (NFLD). Nonalcoholic fatty liver disease is the accumulat...

What is the current status of trial NCT01833403?

This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2013-04. Estimated completion is 2014-03.

What interventions are being tested in trial NCT01833403?

The interventions under investigation include: Hyperinsulinemic-euglycemic clamp (OTHER).

Who is sponsoring clinical trial NCT01833403?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01833403's enrollment target sits among peer trials

4 1996th of 2000 higher than 5 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01833403, the US trial registry maintained by the National Library of Medicine. NCT01833403 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.